FORT WORTH, Texas, Sept. 9 /PRNewswire-FirstCall/ -- Wound Care
Innovations, LLC, a subsidiary of Wound Management Technologies, Inc., (OTC
Bulletin Board: WNDM), announced today that it will be presenting at the New
Cardiovascular Horizons and Management of the Diabetic Foot & Wound Healing
(NCVH) conference in New Orleans September 10-13. NCVH is one of the largest
multidisciplinary conferences in the country bringing together the leaders in
the wound care market place. There are over 3500 expected attendees and one of
the most distinguished faculty lists in the wound care industry. One of the
featured speakers is Dr. Gary Rothenberg, DPM, Miami, FL who will present on
Emerging Use of Topical "Biologics" in Limb Salvage: Role of "Activated
Collagen" in Multimodality Treatments.
"We are excited about exhibiting at the NCVH conference and showcasing our
products at the event," states Cathy Bradshaw, President of Wound Care
Innovations. "It is an excellent opportunity to be with the industry leaders
and promote our advanced wound care product, CellerateRx(R) especially at such
a crucial point of our revenue generation cycle of the product."
The Company also has announced that they have expanded their sales team
through the addition of Lisa DiRisio as Senior Account Manager. Lisa, who has
significant experience in the wound care industry from her time at Smith &
Nephew, will also be in attendance at the conference. Cathy Bradshaw further
states, "We are very excited to have Lisa join our team and bring a wealth of
value to the Company through her background and wound care relationships. Post
our announcement of our independent studies of CellerateRX we have had
multiple revenue leads and believe through the further build out of our team
with individuals such as Lisa that we will be able to significantly expand our
revenue generation in the near term."
About Wound Management Technologies, Inc.:
Wound Management Technologies, Inc. (OTC Bulletin Board: WNDM), with its
corporate headquarters in Fort Worth, Texas, markets and distributes wound
care products to the healthcare market under patented technology licensed to
the Company. The Company is positioned and seeks to be a leading provider of
wound care products. For more information on the Company please visit the
Company's Website at http://www.Celleraterx.com .
"Safe Harbor" Statement: Under The Private Securities Litigation Reform
Act of 1995: The statements in the press release that relate to the company's
expectations with regard to the future impact on the company's results from
new products in development are "forward-looking statements," within the
meaning of the Private Securities Litigation Reform Act of 1995. Since this
information may contain statements that involve risk and uncertainties and are
subject to change at any time, the company's actual results may differ
materially from expected results. This document may contain forward-looking
statements concerning the Company's operations, current and future performance
and financial condition. These items involve risks and uncertainties such as
product demand, market and customer acceptance, the effect of economic
conditions, competition, pricing, the ability to consummate and integrate
acquisitions, and other risks and uncertainties detailed in the Company's SEC
filings. The Company undertakes no obligation to revise any of these
statements to reflect the future circumstances or the occurrence of
unanticipated events.
For Further Information:
Product Information Shareholder Relations
Cathy Bradshaw Lucy Singleton
President Secretary
954-315-9242 817-820-7080
SOURCE Wound Management Technologies, Inc.
